NEVVI Medicare utilization intelligence

← back

WELLS, JAMESM.D. NPI 1164509873 Clinician

Hematology-Oncology · WEST COLUMBIA, SC

Specialty Hematology-Oncology — from billed Medicare claims
Trained MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE — medical school, self-reported to CMS
In practice about 21 years since medical school (class of 2005, self-reported to CMS)
Location WEST COLUMBIA, SC · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 90 codes billed · 184,517 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
LEXINGTON HEALTH INC
2021–2026
LEXINGTON COUNTY HEALTH SERVICES DISTRICT INC
2019–2021

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-11

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J9271 Injection, pembrolizumab, 1 mg
J1453 Injection, fosaprepitant, 1 mg
J9299 Injection, nivolumab, 1 mg
J9263 Injection, oxaliplatin, 0.5 mg
J0897 Injection, denosumab, 1 mg
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
J9144 Injection, daratumumab, 10 mg and hyaluronidase-fihj
J0185 Injection, aprepitant, 1 mg
J9267 Injection, paclitaxel, 1 mg
J9022 Injection, atezolizumab, 10 mg
J1100 Injection, dexamethasone sodium phosphate, 1 mg
J9041 Injection, bortezomib, 0.1 mg
J9312 Injection, rituximab, 10 mg
J2469 Injection, palonosetron hcl, 25 mcg
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
36415 Insertion of needle into vein for collection of blood sample
80048 Blood test, basic group of blood chemicals (calcium, total)
80076 Liver function blood test panel
J0461 Injection, atropine sulfate, 0.01 mg
J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units
J1626 Injection, granisetron hydrochloride, 100 mcg
J9190 Injection, fluorouracil, 500 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
Q5111 Injection, pegfilgrastim-cbqv (udenyca), biosimilar, 0.5 mg
J9201 Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg
96375 Injection of additional new drug or substance into vein
96413 Administration of chemotherapy into vein, 1 hour or less
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
J9181 Injection, etoposide, 10 mg
96372 Injection of drug or substance under skin or into muscle
J9045 Injection, carboplatin, 50 mg
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J9217 Leuprolide acetate (for depot suspension), 7.5 mg
J9060 Injection, cisplatin, powder or solution, 10 mg
83735 Magnesium level
A9595 Piflufolastat f-18, diagnostic, 1 millicurie
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
J3480 Injection, potassium chloride, per 2 meq
J0640 Injection, leucovorin calcium, per 50 mg
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
J3475 Injection, magnesium sulfate, per 500 mg
96417 Administration of additional new drug or substance into vein, 1 hour or less
83615 Lactate dehydrogenase (enzyme) level
84443 Blood test, thyroid stimulating hormone (tsh)
84439 Thyroxine (thyroid chemical), free
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
82728 Ferritin (blood protein) level
83540 Iron level
83550 Iron binding capacity
84153 Psa (prostate specific antigen) measurement, total
96415 Administration of chemotherapy into vein, each additional hour
78815 Nuclear medicine study from skull base to mid-thigh with ct scan
J7030 Infusion, normal saline solution , 1000 cc
82378 Carcinoembryonic antigen (cea) protein level
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries
96368 Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
71260 Ct scan of chest with contrast
74177 Ct scan of abdomen and pelvis with contrast
96416 Administration of prolonged chemotherapy into vein
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
96360 Infusion into a vein for hydration, 31-60 minutes
96411 Administration of additional new drug or substance into vein using push technique
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
J7050 Infusion, normal saline solution, 250 cc
J3489 Injection, zoledronic acid, 1 mg
82565 Blood creatinine level
80053 Blood test, comprehensive group of blood chemicals
J1200 Injection, diphenhydramine hcl, up to 50 mg
82024 Adrenocorticotropic hormone (acth) level
99222 Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes
71250 Ct scan of chest without contrast
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
81003 Automated urinalysis test
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
J2997 Injection, alteplase recombinant, 1 mg
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
99203 New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
96409 Administration of chemotherapy into vein using push technique
99231 Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
99204 New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
J3490 Unclassified drugs
74176 Ct scan of abdomen and pelvis without contrast
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
96374 Injection of drug or substance into vein

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.